OR WAIT null SECS
August 20, 2024
Genentech will have access to Sangamo’s capsid delivery platform and epigenetic regulation capabilities to develop genomic medicines for certain neurodegenerative diseases.
February 02, 2024
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
December 06, 2023
Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.
November 02, 2023
A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.
October 13, 2023
Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.
October 11, 2023
Under this agreement, Acuitas Therapeutics’ LNP technology platform will be transferred to BIOVECTRA for use in manufacturing mRNA-based therapies.
February 15, 2023
The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.
November 03, 2022
Adherence to detail and thorough project management are required for successful tech transfer and scale up.
November 02, 2022
In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.
October 25, 2022
Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.